These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31410472)

  • 1. Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system.
    Josipović G; Tadić V; Klasić M; Zanki V; Bečeheli I; Chung F; Ghantous A; Keser T; Madunić J; Bošković M; Lauc G; Herceg Z; Vojta A; Zoldoš V
    Nucleic Acids Res; 2019 Oct; 47(18):9637-9657. PubMed ID: 31410472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner.
    O'Geen H; Bates SL; Carter SS; Nisson KA; Halmai J; Fink KD; Rhie SK; Farnham PJ; Segal DJ
    Epigenetics Chromatin; 2019 May; 12(1):26. PubMed ID: 31053162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing the CRISPR-Cas9 system for targeted DNA methylation.
    Vojta A; Dobrinić P; Tadić V; Bočkor L; Korać P; Julg B; Klasić M; Zoldoš V
    Nucleic Acids Res; 2016 Jul; 44(12):5615-28. PubMed ID: 26969735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs.
    Pflueger C; Tan D; Swain T; Nguyen T; Pflueger J; Nefzger C; Polo JM; Ford E; Lister R
    Genome Res; 2018 Aug; 28(8):1193-1206. PubMed ID: 29907613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD.
    Kantor B; Tagliafierro L; Gu J; Zamora ME; Ilich E; Grenier C; Huang ZY; Murphy S; Chiba-Falek O
    Mol Ther; 2018 Nov; 26(11):2638-2649. PubMed ID: 30266652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editing of DNA Methylation Using dCas9-Peptide Repeat and scFv-TET1 Catalytic Domain Fusions.
    Morita S; Horii T; Hatada I
    Methods Mol Biol; 2018; 1767():419-428. PubMed ID: 29524149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases.
    Lin L; Liu Y; Xu F; Huang J; Daugaard TF; Petersen TS; Hansen B; Ye L; Zhou Q; Fang F; Yang L; Li S; Fløe L; Jensen KT; Shrock E; Chen F; Yang H; Wang J; Liu X; Xu X; Bolund L; Nielsen AL; Luo Y
    Gigascience; 2018 Mar; 7(3):1-19. PubMed ID: 29635374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
    Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
    Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of Cell Lines Stably Expressing dCas9-Fusions to Address Kinetics of Epigenetic Editing.
    Goubert D; Koncz M; Kiss A; Rots MG
    Methods Mol Biol; 2018; 1767():395-415. PubMed ID: 29524148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review on CRISPR/Cas-based epigenetic regulation in plants.
    Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
    Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized Protocol for the Regulation of DNA Methylation and Gene Expression Using Modified dCas9-SunTag Platforms.
    Morita S; Horii T; Hatada I
    Methods Mol Biol; 2024; 2842():155-165. PubMed ID: 39012594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient Targeted DNA Methylation with dCas9-Coupled DNMT3A-DNMT3L Methyltransferase.
    Bashtrykov P; Rajaram N; Jeltsch A
    Methods Mol Biol; 2023; 2577():177-188. PubMed ID: 36173573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein engineering strategies for improving the selective methylation of target CpG sites by a dCas9-directed cytosine methyltransferase in bacteria.
    Xiong T; Rohm D; Workman RE; Roundtree L; Novina CD; Timp W; Ostermeier M
    PLoS One; 2018; 13(12):e0209408. PubMed ID: 30562388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation-independent long-term epigenetic silencing with dCRISPR/Cas9 fusion proteins.
    Ding L; Schmitt LT; Brux M; Sürün D; Augsburg M; Lansing F; Mircetic J; Theis M; Buchholz F
    Life Sci Alliance; 2022 Jun; 5(6):. PubMed ID: 35288457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.
    Huang YH; Su J; Lei Y; Brunetti L; Gundry MC; Zhang X; Jeong M; Li W; Goodell MA
    Genome Biol; 2017 Sep; 18(1):176. PubMed ID: 28923089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
    Choudhury SR; Cui Y; Lubecka K; Stefanska B; Irudayaraj J
    Oncotarget; 2016 Jul; 7(29):46545-46556. PubMed ID: 27356740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific recruitment of epigenetic factors with a modular CRISPR/Cas system.
    Anton T; Bultmann S
    Nucleus; 2017 May; 8(3):279-286. PubMed ID: 28448738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active fusions of Cas9 orthologs.
    Josipović G; Zoldoš V; Vojta A
    J Biotechnol; 2019 Aug; 301():18-23. PubMed ID: 31158410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inheritable CRISPR based epigenetic modification in a fungus.
    Chen X; Moran Torres JP; Li Y; Lugones LG; Wösten HAB
    Microbiol Res; 2023 Jul; 272():127397. PubMed ID: 37141850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9-mediated demethylation of FOXP3-TSDR toward Treg-characteristic programming of Jurkat T cells.
    Wilk C; Effenberg L; Abberger H; Steenpass L; Hansen W; Zeschnigk M; Kirschning C; Buer J; Kehrmann J
    Cell Immunol; 2022 Jan; 371():104471. PubMed ID: 34954490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.